Loading profile...
Martin Dillon
TruScreen CEO, Martin Dillon commented: "Adding South Africa is a major milestone in our African distribution strategy. The majority of African nations are emerging economies with limited or no screening laboratory infrastructure. The TruScreen technology will assist to reduce deaths from cervical cancer. TruScreen is also well suited to increase the screening rates in 47 WHO member nations looking to achieve 70% screening rates by 2030."
About this profile
This profile aggregates publicly-available information from 6 source registers for the purpose of cross-platform governance and transparency research. Every fact is sourced from one of the public publications listed below; the aggregation, presentation and any analytical observations are published by NZXplorer.
Source registers used on this page
- NZX market announcements and continuous-disclosure filings
- Audited annual reports lodged with NZX
- FMA Disclose Register (substantial product holders, insider trades)
- NZ Companies Office records (Companies Act 1993 §215)
- NZ Government Gazette appointment notices
- Issuer earnings webcasts and investor presentations
If anything on this page is wrong, missing context, or warrants a formal right-of-reply, use the dispute & right-of-reply form. Our editorial floor — what we always remove on request, the search-engine indexing policy, and the Privacy Act access / correction routes — is set out on Data Principles.
University of Sydney